The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Gangloff Scott A. since 2016.
This trader's CIK number is 1663253.
At the time of last reporting, Gangloff Scott A. was the Chief Technology Officer of Akero Therapeutics, Inc.. (stock ticker symbol AKRO).
Also see all insider trading activities at Akero Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | ONS | 0 | $0 | 37,369 | $140,133 | 115,942 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | AKRO | 0 | $0 | 848 | $46,504 | 2,600 | $51,012 |
1. Outlook Therapeutics, Inc. (ONS)
2. Akero Therapeutics, Inc. (AKRO)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-11-11 | ONS | Sale | 37,369 | 3.75 | 140,133 |
| 2016-11-09 | ONS | Option Ex | 115,942 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-15 | AKRO | Option Ex | 2,600 | 19.62 | 51,012 |
| 2025-06-18 | AKRO | Sale | 848 | 54.84 | 46,504 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gangloff Scott A. (Chief Technology Officer of Akero Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.